loading...| Preferred Name |
Brimonidine |
|
| Synonyms |
|
|
| Definitions |
An imidazole derivative and a selective alpha-2 adrenergic receptor agonist. Upon ocular administration, brimonidine acts on the blood vessels causing them to constrict which leads to a decrease in the production of aqueous humor. Brimonidine also enhances the uveoscleral outflow of aqueous humor. This reduces intraocular pressure. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C65269 |
|
| CAS_Registry |
59803-98-4 |
|
| CHEBI_ID |
CHEBI:3175 |
|
| Chemical_Formula |
C11H10BrN5 |
|
| code |
C65269 |
|
| Contributing_Source |
FDA |
|
| definition |
An imidazole derivative and a selective alpha-2 adrenergic receptor agonist. Upon ocular administration, brimonidine acts on the blood vessels causing them to constrict which leads to a decrease in the production of aqueous humor. Brimonidine also enhances the uveoscleral outflow of aqueous humor. This reduces intraocular pressure. |
|
| FDA_UNII_Code |
E6GNX3HHTE |
|
| Has_Salt_Form | ||
| in_subset | ||
| label |
Brimonidine |
|
| Legacy Concept Name |
Brimonidine |
|
| Preferred_Name |
Brimonidine |
|
| prefixIRI |
NCIT:C65269 |
|
| prefLabel |
Brimonidine |
|
| Semantic_Type |
Pharmacologic Substance |
|
| UMLS_CUI |
C0525227 |
|
| subClassOf |